Healthpeak Properties (NYSE:DOC) Raised to “Outperform” at BNP Paribas

Healthpeak Properties (NYSE:DOC) was upgraded by analysts at BNP Paribas from a “neutral” rating to an “outperform” rating in a research report issued on Friday, MarketBeat Ratings reports. The firm presently has a $21.00 price objective on the real estate investment trust’s stock, up from their previous price objective of $19.00. BNP Paribas’ price objective indicates a potential upside of 11.70% from the stock’s previous close.

Several other research firms have also recently weighed in on DOC. StockNews.com raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Friday, April 5th. Compass Point decreased their price objective on Healthpeak Properties from $19.00 to $18.00 and set a “buy” rating for the company in a report on Tuesday, January 2nd. KeyCorp restated a “sector weight” rating on shares of Healthpeak Properties in a report on Friday, January 5th. Wells Fargo & Company assumed coverage on shares of Healthpeak Properties in a research note on Monday, March 25th. They issued an “equal weight” rating and a $19.00 price target for the company. Finally, Mizuho restated a “buy” rating and issued a $22.00 price objective on shares of Healthpeak Properties in a report on Monday. Six analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $18.36.

Healthpeak Properties Trading Up 2.5 %

Healthpeak Properties stock traded up $0.46 during trading hours on Friday, reaching $18.80. The company had a trading volume of 3,010,423 shares, compared to its average volume of 7,223,459. The firm has a market cap of $13.34 billion, a price-to-earnings ratio of 33.50, a P/E/G ratio of 1.84 and a beta of 1.02. Healthpeak Properties has a 12-month low of $15.24 and a 12-month high of $22.38. The company has a debt-to-equity ratio of 1.00, a current ratio of 0.67 and a quick ratio of 0.67. The company has a 50-day moving average price of $16.52 and a 200 day moving average price of $13.69.

Institutional Investors Weigh In On Healthpeak Properties

Hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC increased its stake in Healthpeak Properties by 274.6% during the fourth quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock worth $54,000 after acquiring an additional 2,985 shares during the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of Healthpeak Properties by 42.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 5,750 shares of the real estate investment trust’s stock valued at $70,000 after buying an additional 1,712 shares during the period. Quadrant Capital Group LLC raised its holdings in shares of Healthpeak Properties by 645.4% in the fourth quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock valued at $128,000 after acquiring an additional 8,352 shares in the last quarter. Stratos Wealth Partners LTD. purchased a new stake in Healthpeak Properties in the fourth quarter worth about $134,000. Finally, Envestnet Portfolio Solutions Inc. bought a new position in Healthpeak Properties during the 3rd quarter worth about $124,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.